Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Agnieszka Szymczyk
Observed names:
A. Szymczyk,
AGNIESZKA SZYMCZYK,
Szymczyk , Agnieszka,
Szymczyk, Agnieszka
Institution:
National Medical Institute of the Ministry of Interior and Administration
Observed institutions:
Warsaw University of Technology,
Medical University of Lublin,
University of Łódź,
Lublin Oncology Center,
Ministry of Interior and Administration,
National Medical Institute of the Ministry of Interior and Administration
show all 6
ORCID:
0000-0001-8347-7557
Observed ORCID:
0000-0001-8347-7557
OpenAlex ID:
A5004096103
The Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios as New Prognostic Factors in Hematological Malignancies – A Narrative Review
2020
·
Paulina Stefaniuk
, Agnieszka Szymczyk
, et al.
·
Cancer Management and Research
·
122
PDF
Assessment of red blood cell distribution width as a prognostic marker in chronic lymphocytic leukemia
2016
·
Monika Podhorecka
, Dorota Halicka
, et al.
·
Oncotarget
·
60
PDF
Metallothionein 2A genetic polymorphisms and risk of ductal breast cancer
2012
·
Anna Krześlak
, Ewa Forma
, et al.
·
Clinical and Experimental Medicine
·
47
PDF
Abnormal microRNA expression in the course of hematological malignancies
2018
·
Agnieszka Szymczyk
, Arkadiusz Macheta
, et al.
·
Cancer Management and Research
·
42
PDF
Changes in T-cell subpopulations and cytokine network during early period of ibrutinib therapy in chronic lymphocytic leukemia patients: the significant decrease in T regulatory cells number
2017
·
Monika Podhorecka
, Aneta Goracy
, et al.
·
Oncotarget
·
39
PDF
Effect of metallothionein 2A gene polymorphism on allele-specific gene expression and metal content in prostate cancer
2013
·
Anna Krześlak
, Ewa Forma
, et al.
·
Toxicology and Applied Pharmacology
·
39
Metallothionein 2A genetic polymorphisms and risk of prostate cancer in a Polish population
2012
·
Ewa Forma
, Anna Krzeslak
, et al.
·
Cancer Genetics
·
32
Response to anti‐SARS‐CoV ‐2 mRNA vaccines in multiple myeloma and chronic lymphocytic leukemia patients
2022
·
Joanna Zaleska
, Paulina Kwasnik
, et al.
·
International Journal of Cancer
·
26
Long-term Efficacy of Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia: Results of the Polish Adult Leukemia Study Group Observational Study
2020
·
BARTOSZ PULA
, ELZBIETA ISKIERKA-JAZDZEWSKA
, et al.
·
Anticancer Research
·
23
PDF
Association between the c.*229C>T polymorphism of the topoisomerase IIβ binding protein 1 (TopBP1) gene and breast cancer
2012
·
Ewa Forma
, Ewa Brzeziańska
, et al.
·
Molecular Biology Reports
·
23
PDF
Imbalance in circulatory iNKT, Th17 and T regulatory cell frequencies in patients with B‑cell non‑Hodgkin's lymphoma
2017
·
Iwona Hus
, Agnieszka Bojarska‑Junak
, et al.
·
Oncology Letters
·
18
COVID-19 in Adult Patients with Hematological Malignancies—Lessons Learned after Three Years of Pandemic
2023
·
Iwona Hus
, Agnieszka Szymczyk
, et al.
·
Biology
·
17
PDF
Efficacy of siltuximab in the treatment of idiopathic multicentric castleman disease, the first Polish, real-world experience with long-term observation
2021
·
Beata Ostrowska
, Agnieszka Szymczyk
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
15
Mean Platelet Volume Has Prognostic Value in Chronic Lymphocytic Leukemia
2020
·
Marta Masternak
, Bartosz Puła
, et al.
·
Cancer Management and Research
·
15
PDF
Target Therapy in Hematological Malignances: New Monoclonal Antibodies
2014
·
Monika Podhorecka
, Justyna Markowicz
, et al.
·
International Scholarly Research Notices
·
14
PDF
Hodgkin's variant of Richter's transformation during ibrutinib therapy in a series of CLL patients; the Polish Adult Leukemia Group report ( PALG )
2017
·
Krzysztof Jamroziak
, Agnieszka Szymczyk
, et al.
·
European Journal Of Haematology
·
13
Comparable Efficacy of Idelalisib Plus Rituximab and Ibrutinib in Relapsed/refractory Chronic Lymphocytic Leukemia: A Retrospective Case Matched Study of the Polish Adult Leukemia Group (PALG)
2018
·
BARTOSZ PUŁA
, BOŻENA KATARZYNA BUDZISZEWSKA
, et al.
·
Anticancer Research
·
12
PDF
The challenge of diagnosing and classifying eosinophilia and eosinophil disorders: A review
2024
·
Agnieszka Szymczyk
, Jakub Jaworski
, et al.
·
Central European Journal of Immunology
·
11
Therapeutic Options for Patients with TP53 Deficient Chronic Lymphocytic Leukemia: Narrative Review
2021
·
Paulina Stefaniuk
, Julia Onyszczuk
, et al.
·
Cancer Management and Research
·
10
PDF
Danazol induces apoptosis and cytotoxicity of leukemic cells alone and in combination with purine nucleoside analogs in chronic lymphocytic leukemia
2015
·
Monika Podhorecka
, Arkadiusz Macheta
, et al.
·
Annals of Hematology
·
10
PDF
Topoisomerase IIβ Binding Protein 1 c.*229C>T (rs115160714) Gene Polymorphism and Endometrial Cancer Risk
2013
·
Ewa Forma
, Katarzyna Wójcik-Krowiranda
, et al.
·
Pathology & Oncology Research
·
10
PDF
High efficacy and safety of VTD as an induction protocol in patients with newly diagnosed multiple myeloma eligible for high dose therapy and autologous stem cell transplantation: A report of the Polish Myeloma Study Group
2019
·
Iwona Hus
, Joanna Mańko
, et al.
·
Oncology Letters
·
9
PDF
Central nervous involvement by chronic lymphocytic leukaemia
2017
·
Dariusz Szczepanek
, Ewa Wąsik-Szczepanek
, et al.
·
Neurologia i Neurochirurgia Polska
·
9
Venetoclax and obinutuzumab in first-line treatment of unfit patients with CLL – real-life data analysis of the Polish Adult leukemia group
2025
·
Klaudia Zielonka
, Błażej Izdebski
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
8
PDF
The Role of Megakaryocyte Assessment in Bone Marrow Cytology
2025
·
Monika Błocka-Gumowska
, Iwona Hus
, et al.
·
Journal of Clinical Medicine
·
8
PDF
Show more works
View as search
Works count:
81
Citation count:
704
H-index:
14
I10-index:
21
Year
Topic
Type